Search Results 501-510 of 3828 for 搜索痕迹咨询邮箱：lgooxc@hotmail.com

  1. Consent for Prenatal Screening in Diverse Populations (Aim 1) - Mayo Clinic

    Prenatal providers will identify key clinical components of JITC and potential barriers to informed decision-making for PGS that JITC may have the potential to ...

  2. Biorepository of Biosamples From Patients With Psoriatic Arthritis in the Spondyloarthritis Research Program - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Faculty - Department of Quantitative Health Sciences - Mayo Clinic Research

    Expert faculty members guide research and education in Mayo Clinic's Department of Quantitative Health Sciences.

  4. Faculty and Staff - Department of Immunology - Mayo Clinic Research

    An expert faculty and staff lead research in the Department of Immunology at Mayo Clinic.

  5. Laboratories - Mayo Clinic Research

    c. Cancer Biology and Translational Research: John A. Copland III · Cancer Research and Cellular Therapies: Januario E. Castro · Cardiovascular Tissue ...

  6. Contact - Precision Neurotherapeutics Innovation Program - Mayo Clinic Research

    Kristin R. Swanson, Ph.D. · Phone: 480-342-1914 · Email: swanson.kristin@mayo.edu ...

  7. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

    The study will include a Phase 1 part to determine the recommended dose of JCARH125 in subjects with relapsed and/or refractory multiple myeloma, followed by a ...

  8. Faculty - Department of Quantitative Health Sciences - Mayo Clinic Research

    Expert faculty members guide research and education in Mayo Clinic's Department of Quantitative Health Sciences.

  9. Faculty - Department of Quantitative Health Sciences - Mayo Clinic Research

    Expert faculty members guide research and education in Mayo Clinic's Department of Quantitative Health Sciences.

  10. An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab - Mayo Clinic

    2. To examine the safety and efficacy of initial alemtuzumab treatment in this study for patients who received Rebif® (interferon beta-1a) as their study ...